Auf dieser Seite
NGNE Neurogene Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 11, 2026
$25,65
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$16,3052-Wochen-Tief
$43,6652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$406M
P/E
-6.1
EPS
$-4.24
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$16–$44
Analystenbewertung
BUY
Kursziel
$80
P/E
-6.1
ROE
-33.6%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
NGNE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$25.65
Marktkapitalisierung (MRQ)
$406M
P/E
-6.1
EPS
$-4.24
Umsatz
$0
ROE
-33.6%
52W-Spanne
$16–$44
NGNE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 19. Dezember 2023 | 1-for-4 | Umgekehrt |
| 25. September 2023 | 1-for-5 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02018-12-31 → 2025-12-31
EPS$-4.242020-12-31 → 2025-12-31
Freier Cashflow$-78M2016-12-31 → 2025-12-31
Nettogewinnmarge·2022-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | NGNE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -6.15-Jahres-Durchschnitt ≈-21.6 | ≈-21.6 | · | · | |
| K/B (MRQ) | 1.95-Jahres-Durchschnitt ≈7.4 | ≈7.4 | 2.9 | Unterbewertet | |
| Kurs / FCF (TTM) | -4.65-Jahres-Durchschnitt ≈-20.7 | ≈-20.7 | · | · | |
| Kurs / Cashflow (TTM) | -4.75-Jahres-Durchschnitt ≈-21.9 | ≈-21.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.55-Jahres-Durchschnitt ≈1.2 | ≈1.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | NGNE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -28.9%5-Jahres-Durchschnitt ≈-30.3% | ≈-30.3% | -17.8% | Schwach | |
| ROE | -33.6%5-Jahres-Durchschnitt ≈-549.1% | ≈-549.1% | -18.7% | Schwach | |
| ROIC | -39.0% | · | -32.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | NGNE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 10.65-Jahres-Durchschnitt ≈14.4 | ≈14.4 | 11.6 | Geringe Liquidität | |
| Quick Ratio | 16.45-Jahres-Durchschnitt ≈14.2 | ≈14.2 | 2.9 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | NGNE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
5.9%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-1.53 | $-1.45 | -5.4% |
| 31. März 2026 | Mai 8, 2026 | $-1.39 | $-1.32 | -5.1% |
| 31. Dezember 2025 | $-1.17 | $-1.21 | 3.5% | |
| 30. September 2025 | $-0.99 | $-1.27 | 22.4% | |
| 30. Juni 2025 | $-1.05 | $-1.18 | 11.1% | |
| 31. März 2025 | $-1.08 | $-1.08 | 0.42% | |
| 31. Dezember 2024 | $-0.99 | $-1.15 | 14.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $925.0K | $0 | · | · | · | · | $25M | |
| R&D Expense | $75M | $61M | $44M | $48M | $39M | · | · | $42M | |
| SG&A Expense | $28M | $23M | $11M | $9M | $22M | $17M | $19M | $16M | |
| Operating Expenses | $103M | $84M | $56M | $57M | $61M | · | $71M | $58M | |
| Operating Income | $-103M | $-83M | $-56M | $-57M | $-61M | $-34M | $-71M | $-33M | |
| Interest Expense | · | · | $12.0K | $2.0K | · | · | $1.0K | $4.0K | |
| Interest Income | $12M | $8M | $3M | $1M | · | · | · | · | |
| Other Non-op | $13M | $7M | · | $-42.0K | $-13.0K | $-44.0K | $-9.0K | $1M | |
| Pretax Income | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| EPS (Basic) | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 | $-0.64 | · | · | |
| EPS (Diluted) | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 | $-0.64 | · | · | |
| Shares (Basic) | 21,326,283 | 17,567,082 | · | 55,221,161 | 55,041,662 | 51,825,022 | · | · | |
| Shares (Diluted) | 21,326,283 | 17,567,082 | · | 55,221,161 | 55,041,662 | 51,825,022 | · | · | |
| EBITDA | $-100M | $-79M | $-52M | $-58M | $-59M | $-33M | $-71M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $104M | $137M | $148M | $82M | $142M | $193M | $143M | $77M | |
| Short-term Investments | $165M | $176M | $49M | $0 | $0 | · | · | · | |
| Prepaid Expense | $3M | $4M | $3M | $3M | · | · | · | · | |
| Other Current Assets | $168.0K | $981.0K | $1M | $630.0K | $2M | $2M | $503.0K | · | |
| Current Assets | $272M | $316M | $200M | $85M | $144M | $195M | $144M | $77M | |
| PP&E (Net) | $13M | $15M | $17M | $20M | $6M | $4M | $2M | $400.0K | |
| PP&E (Gross) | $27M | $27M | $25M | $25M | · | $4M | $3M | $843.0K | |
| Accum. Depreciation | $14M | $11M | $8M | $5M | · | $585.0K | $688.0K | $443.0K | |
| Intangibles | · | · | · | $0 | $128.0K | $347.0K | $567.0K | · | |
| Other Non-current Assets | $1M | $975.0K | $764.0K | $0 | $2M | $2M | $30.0K | · | |
| Total Assets | $289M | $336M | $223M | $109M | $163M | $211M | $147M | $78M | |
| Accounts Payable | $2M | $1M | $3M | $625.0K | $7M | $7M | $4M | · | |
| Accrued Liabilities | $11M | $10M | $17M | $5M | · | · | · | · | |
| Current Liabilities | $16M | $15M | $23M | $7M | $9M | $8M | $5M | $5M | |
| Capital Leases | $7M | $9M | $12M | $4M | $12M | $11M | $447.0K | $6.0K | |
| Other Non-current Liabilities | $51.0K | $51.0K | $203.0K | $0 | · | · | · | $319.0K | |
| Total Liabilities | $24M | $25M | $37M | $11M | $20M | $19M | $5M | $5M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $618M | $573M | $373M | $5M | $536M | $524M | $441M | $303M | |
| Retained Earnings | $-353M | $-262M | $-187M | $-151M | $-393M | $-333M | $-300M | $-230M | |
| AOCI | · | · | · | $-21.0K | $0 | · | · | · | |
| Stockholders' Equity | $265M | $310M | $186M | $-146M | $-92M | $191M | $142M | $73M | |
| Liabilities + Equity | $289M | $336M | $223M | $109M | $163M | $211M | $147M | $78M | |
| Shares Outstanding | 15,489,800 | 14,854,725 | 12,823,665 | 0 | 0 | 42,196,296 | 37,996,849 | 23,537,368 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $1M | $785.0K | $340.0K | $289.0K | |
| Stock-based Comp | $14M | $8M | $1M | $1M | $12M | $6M | $8M | $5M | |
| Amort. of Intangibles | · | · | · | $100.0K | $200.0K | $200.0K | · | · | |
| Restructuring | · | · | · | $1M | · | $0 | · | · | |
| Other Non-cash | $-4M | $-7M | $-20M | $2M | $271.0K | $2M | $46M | · | |
| Operating Cash Flow | $-77M | $-71M | $-51M | $-53M | $-48M | $-25M | $-15M | $-32M | |
| CapEx | $1M | $808.0K | $321.0K | $2M | $3M | $2M | $879.0K | $49.0K | |
| Investing Cash Flow | $14M | $-125M | $26M | $-2M | $-3M | $-2M | $-688.0K | $56M | |
| Stock Issued | $30M | $0 | $92M | $0 | $0 | $72M | $81M | · | |
| Net Stock Activity | $30M | $0 | $92M | · | $0 | $72M | $86M | · | |
| Financing Cash Flow | $30M | $184M | $92M | $67M | $732.0K | $77M | $82M | $570.0K | |
| Net Change in Cash | $-33M | $-12M | $67M | $11M | $-50M | $50M | $66M | $25M | |
| Free Cash Flow | $-78M | $-71M | $-52M | $-47M | $-51M | $-27M | $-16M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -8930.3% | · | -3735.6% | · | · | · | · | |
| Net Margin | · | -8123.7% | · | -3638.2% | · | · | · | · | |
| Pretax Margin | · | -8123.7% | · | -3639.6% | · | · | · | · | |
| EBITDA Margin | · | -8584.9% | · | -3636.9% | · | · | · | · | |
| ROA | -28.9% | -26.9% | -21.9% | -41.2% | -32.5% | -18.6% | -61.8% | · | |
| ROE | -33.6% | -33.6% | -2580.2% | -57.6% | -40.8% | -17.0% | -66.6% | · | |
| ROIC | -39.0% | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.6 | 20.8 | 8.7 | 9.0 | 16.7 | 24.7 | 30.3 | · | |
| Quick Ratio | 16.4 | 20.6 | 8.6 | 8.7 | 16.5 | 24.4 | 30.2 | · | |
| Interest Coverage | · | · | -4631.9 | · | · | · | -70959.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.10 | $20.89 | $14.51 | $2.21 | $3.36 | $4.53 | $3.73 | · | |
| Revenue / Share | $0.00 | $0.05 | · | $0.03 | · | · | · | · | |
| Cash Flow / Share | $-3.62 | $-4.02 | · | $-0.83 | $-0.86 | · | · | · | |
| Cash / Share | $6.70 | $9.19 | $11.56 | $0.89 | $3.36 | $4.56 | $3.77 | · | |
| EPS (TTM) | $-4.24 | $-4.28 | $-60.79 | $-1.04 | $-1.10 | $-0.64 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $925.0K | $0 | · | · | · | · | $25M | |
| Net Income TTM | $-90M | $-75M | $-36M | $-55M | $-61M | $-33M | $-69M | $-32M | |
| Market Cap | $319M | $340M | $249M | $434M | $4.09B | $11.90B | $9.36B | · | |
| P/E | -4.9 | -5.3 | -0.3 | -9.8 | -87.6 | -440.6 | · | · | |
| P/S | · | 367.1 | · | · | · | · | · | · | |
| P/B | 1.2 | 1.1 | 1.3 | 4.6 | 28.6 | 62.2 | 66.1 | · | |
| P / Tangible Book | 1.2 | 1.1 | 1.3 | · | · | 62.3 | · | · | |
| P / Cash Flow | -4.1 | -4.8 | -4.8 | -9.5 | -86.1 | -484.2 | -608.2 | · | |
| P / FCF | -4.1 | -4.8 | -4.8 | -9.3 | -80.5 | -444.1 | -575.3 | · | |
| Earnings Yield | -20.6% | -18.7% | -313.7% | -10.2% | -1.1% | -0.23% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $925.0K | · | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $25M | $25M | $21M | $17M | $19M | $18M | $15M | $16M | $16M | $14M | $12M | $12M | $10M | $10M | $16M | $9M | |
| SG&A Expense | $11M | $8M | $7M | $7M | $7M | $8M | $6M | $6M | $5M | $5M | $3M | $4M | $2M | $3M | $-5M | $4M | |
| Operating Expenses | $37M | $33M | $28M | $24M | $26M | $26M | $22M | $22M | $21M | $19M | $15M | $15M | $13M | $13M | $12M | $14M | |
| Operating Income | $-37M | $-33M | $-28M | $-24M | $-26M | $-26M | $-22M | $-22M | $-20M | $-19M | $-15M | $-15M | $-13M | $-13M | $-12M | $-14M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3.0K | · | · | · | $2.0K | · | · | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $781.0K | $650.0K | $743.0K | $777.0K | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-14.0K | · | $-22.0K | |
| Net Income | $-34M | $-31M | $-25M | $-21M | $-22M | $-23M | $-20M | $-20M | $-18M | $-17M | $2M | $-15M | $-12M | $-12M | $-11M | $-13M | |
| EPS (Basic) | $-1.53 | $-1.39 | $-1.12 | $-0.99 | $-1.05 | $-1.08 | $-1.00 | $-1.19 | $-1.09 | $-1.00 | · | $-32.67 | $-26.68 | $-0.26 | · | $-1.18 | |
| EPS (Diluted) | $-1.53 | $-1.39 | $-1.12 | $-0.99 | $-1.05 | $-1.08 | $-1.00 | $-1.19 | $-1.09 | $-1.00 | · | $-32.67 | $-26.68 | $-0.26 | · | $-1.18 | |
| Shares (Basic) | 22,552,032 | 22,305,734 | · | 21,168,431 | 21,055,378 | 20,996,287 | · | 16,953,443 | 16,941,524 | 16,903,735 | · | 446,255 | 444,465 | 55,420,912 | · | 11,050,207 | |
| Shares (Diluted) | 22,552,032 | 22,305,734 | · | 21,168,431 | 21,055,378 | 20,996,287 | · | 16,953,443 | 16,941,524 | 16,903,735 | · | 446,255 | 444,465 | 55,420,912 | · | 11,050,207 | |
| EBITDA | $-37M | $-33M | · | $-23M | $-25M | $-25M | · | $-21M | $-19M | $-18M | · | $-6M | $-3M | $-15M | · | $-14M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112M | $124M | $104M | $71M | $59M | $71M | $137M | $67M | $111M | $150M | $148M | $25M | $31M | $35M | $82M | $40M | |
| Short-term Investments | $113M | $119M | $165M | $194M | $216M | $222M | $176M | $72M | $43M | $19M | $49M | · | · | · | $0 | · | |
| Prepaid Expense | $4M | $4M | $3M | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $3M | · | · | · | $3M | · | |
| Other Current Assets | $132.0K | $181.0K | $168.0K | $208.0K | $970.0K | $997.0K | $981.0K | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $630.0K | $2M | |
| Current Assets | $229M | $247M | $272M | $271M | $279M | $296M | $316M | $144M | $159M | $174M | $200M | $80M | $84M | $86M | $85M | $109M | |
| PP&E (Net) | $12M | $13M | $13M | $13M | $14M | $15M | $15M | $16M | $16M | $16M | $17M | $484.0K | $561.0K | $2M | $20M | $6M | |
| PP&E (Gross) | $28M | $27M | $27M | $27M | $27M | $27M | $27M | $26M | $26M | $25M | $25M | · | · | · | $25M | · | |
| Accum. Depreciation | $16M | $15M | $14M | $13M | $13M | $12M | $11M | $10M | $10M | $9M | $8M | · | · | · | $5M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $896.0K | $975.0K | $789.0K | $794.0K | $743.0K | $764.0K | $524.0K | $529.0K | $905.0K | $0 | $2M | |
| Total Assets | $244M | $263M | $289M | $288M | $297M | $315M | $336M | $164M | $180M | $195M | $223M | $90M | $94M | $98M | $109M | $127M | |
| Accounts Payable | $3M | $5M | $2M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $3M | $4M | $3M | $5M | $625.0K | $9M | |
| Accrued Liabilities | $15M | $11M | $11M | $9M | $9M | $7M | $10M | $10M | $7M | $7M | $17M | · | · | · | $5M | · | |
| Current Liabilities | $22M | $19M | $16M | $15M | $15M | $14M | $15M | $16M | $13M | $12M | $23M | $5M | $5M | $7M | $7M | $10M | |
| Capital Leases | $5M | $6M | $7M | $7M | $8M | $9M | $9M | $10M | $11M | $12M | $12M | $9M | $10M | $10M | $4M | $11M | |
| Other Non-current Liabilities | $0 | $0 | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $51.0K | $203.0K | $203.0K | · | · | · | $0 | · | |
| Total Liabilities | $27M | $25M | $24M | $22M | $24M | $24M | $25M | $27M | $25M | $25M | $37M | $14M | $14M | $17M | $11M | $21M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $635M | $621M | $618M | $593M | $580M | $577M | $573M | $380M | $378M | $375M | $373M | $547M | $547M | $547M | $5M | $543M | |
| Retained Earnings | $-418M | $-384M | $-353M | $-328M | $-307M | $-285M | $-262M | $-243M | $-223M | $-204M | $-187M | $-472M | $-467M | $-465M | $-151M | $-438M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $-13.0K | $18.0K | · | $-92.0K | |
| Stockholders' Equity | $217M | $238M | $265M | $266M | $273M | $292M | $310M | $137M | $155M | $171M | $186M | $75M | $80M | $81M | $-146M | $106M | |
| Liabilities + Equity | $244M | $263M | $289M | $288M | $297M | $315M | $336M | $164M | $180M | $195M | $223M | $90M | $94M | $98M | $109M | $127M | |
| Shares Outstanding | 15,830,504 | 15,615,786 | 15,489,800 | 14,775,285 | 14,269,264 | 14,929,566 | 14,854,725 | 13,010,867 | 12,989,208 | 12,860,995 | 12,823,665 | 8,805,284 | 44,021,429 | 42,818,346 | 0 | 42,594,602 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $813.0K | $847.0K | $694.0K | $800.0K | $800.0K | $749.0K | $781.0K | $800.0K | $800.0K | $814.0K | $850.0K | $800.0K | $800.0K | $812.0K | $2M | $323.0K | |
| Stock-based Comp | $8M | $4M | $3M | $3M | $3M | $4M | $2M | $2M | $2M | $1M | $355.0K | $-459.0K | $-514.0K | $293.0K | $-6M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $142.0K | $2M | · | · | |
| Other Non-cash | · | $339.0K | · | · | · | $-3M | · | · | · | $-7M | · | · | · | $-349.0K | · | · | |
| Operating Cash Flow | $-24M | $-26M | $-17M | $-20M | $-19M | $-21M | $-17M | $-16M | $-16M | $-22M | $-17M | $-17M | $-10M | $-14M | $-18M | $-9M | |
| CapEx | $354.0K | $281.0K | $128.0K | $127.0K | $148.0K | $780.0K | $116.0K | $167.0K | $460.0K | $65.0K | $128.0K | $-358.0K | $-308.0K | $29.0K | $1M | $322.0K | |
| Investing Cash Flow | $6M | $46M | $30M | $22M | $7M | $-45M | $-103M | $-29M | $-24M | $30M | $26M | $-10M | $-11M | $-29.0K | $65M | $-28M | |
| Stock Issued | · | · | $21M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $6M | $195.0K | $21M | $10M | $54.0K | $4.0K | $190M | $131.0K | $399.0K | $-7M | $94M | $-1M | $87.0K | $107.0K | $66M | $-52.0K | |
| Net Change in Cash | $-12M | $20M | $33M | $12M | $-12M | $-66M | $70M | $-44M | $-39M | $2M | $103M | $-29M | $-21M | $-13M | $114M | $-37M | |
| Free Cash Flow | · | $-26M | · | · | · | $-22M | · | · | · | $-22M | · | · | · | $-13M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -2176.7% | · | · | -533.9% | -312.5% | -1601.6% | · | -2434.5% | |
| Net Margin | · | · | · | · | · | · | · | · | -1999.1% | · | · | -433.9% | -212.5% | -1503.1% | · | -2338.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -2090.2% | · | · | -533.9% | -312.5% | -1566.8% | · | -2434.5% | |
| ROA | -12.7% | -10.7% | · | -9.3% | -9.2% | -8.9% | · | -15.9% | -13.5% | -11.5% | · | -4.2% | -1.8% | -11.5% | · | -8.6% | |
| ROE | -14.1% | -11.7% | · | -10.4% | -10.3% | -9.8% | · | -19.0% | -15.8% | -13.4% | · | -5.0% | -2.1% | -13.4% | · | -10.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.6 | 13.1 | · | 18.4 | 18.1 | 21.0 | · | 9.1 | 12.2 | 14.7 | · | 15.3 | 17.2 | 12.0 | · | 10.6 | |
| Quick Ratio | 10.5 | 12.9 | · | 18.0 | 17.8 | 20.8 | · | 8.8 | 11.8 | 14.3 | · | 4.8 | 6.4 | 5.0 | · | 3.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6259.7 | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.72 | $15.23 | · | $17.97 | $19.15 | $19.54 | · | $10.56 | $11.93 | $13.28 | · | $8.54 | $1.81 | $1.90 | · | $2.48 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | · | · | $0.00 | $0.05 | · | · | $0.09 | $0.02 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-1.17 | · | · | · | $-0.99 | · | · | · | $-1.28 | · | · | · | $-0.24 | · | · | |
| Cash / Share | $7.11 | $7.95 | · | $4.81 | $4.12 | $4.74 | · | $5.12 | $8.55 | $11.67 | · | $2.86 | $0.71 | $0.83 | · | $0.95 | |
| EPS (TTM) | $-5.03 | $-4.55 | · | $-4.12 | $-4.32 | $-4.36 | · | · | · | · | · | · | · | · | · | $-2.02 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-111M | $-99M | · | $-85M | $-84M | $-81M | · | $-53M | $-48M | $-41M | · | $-50M | $-48M | $-52M | · | $-59M | |
| Market Cap | $498M | $315M | · | $256M | $213M | $175M | · | $546M | $473M | $655M | · | $139M | $731M | $599M | · | $545M | |
| P/E | -6.3 | -4.4 | · | -4.2 | -3.5 | -2.7 | · | · | · | · | · | · | · | · | · | -6.3 | |
| P/B | 2.3 | 1.3 | · | 1.0 | 0.8 | 0.6 | · | 4.0 | 3.0 | 3.8 | · | 1.8 | 9.2 | 7.4 | · | 5.2 | |
| P / Tangible Book | 2.3 | 1.3 | · | 1.0 | 0.8 | 0.6 | · | 4.0 | 3.0 | 3.8 | · | 1.8 | 9.2 | 7.4 | · | 5.2 | |
| P / Cash Flow | · | -12.1 | · | · | · | -8.4 | · | · | · | -30.2 | · | · | · | -46.0 | · | · | |
| Earnings Yield | -16.0% | -22.6% | · | -23.8% | -28.9% | -37.2% | · | · | · | · | · | · | · | · | · | -15.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | $925.0K | $0 | · | · |
| Betriebsgewinnmarge % | · | -8930.3% | · | -3735.6% | · |
| Nettoergebnis | $-90M | $-75M | $-36M | $-55M | $-61M |
| Verwässerte EPS | $-4.24 | $-4.28 | · | $-1.04 | $-1.10 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 16.6 | 20.8 | 8.7 | 9.0 | 16.7 |
| Quick Ratio | 16.4 | 20.6 | 8.6 | 8.7 | 16.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-78M | $-71M | $-52M | $-47M | $-51M |
Institutionelle Eigentümer (13F) 120 Einreicher · $562.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
120
Gehaltener Wert
$562.1M
Neue Positionen
21
Geschlossene Positionen
4
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 21 (-3 vs. Vorquartal) | 4 (-7 vs. Vorquartal) | 39 (-5 vs. Vorquartal) | 33 (+18 vs. Vorquartal) | +272K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | $54.003.644 | 1.717.127 | 9,61% | Aktien |
| Casdin Capital, LLC | $48.601.603 | 1.545.361 | 8,65% | Aktien |
| Redmile Group, LLC | $44.413.659 | 1.412.199 | 7,90% | Aktien |
| RTW INVESTMENTS, LP | $42.849.241 | 1.362.456 | 7,62% | Aktien |
| EcoR1 Capital, LLC | $39.983.706 | 1.271.342 | 7,11% | Aktien |
| BlackRock, Inc. | $33.273.565 | 1.057.983 | 5,92% | Aktien |
| BAKER BROS. ADVISORS LP | $31.188.682 | 991.691 | 5,55% | Aktien |
| Balyasny Asset Management L.P. | $25.748.307 | 818.706 | 4,58% | Aktien |
| Trails Edge Capital Partners, LP | $22.483.133 | 714.885 | 4,00% | Aktien |
| TORONTO DOMINION BANK | $21.428.049 | 681.337 | 3,81% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.873.711 | 536.525 | 3,00% | Aktien |
| JENNISON ASSOCIATES LLC | $16.309.405 | 518.582 | 2,90% | Aktien |
| VANGUARD GROUP INC | $13.525.383 | 656.572 | 2,41% | Aktien |
| CITADEL ADVISORS LLC | $12.862.484 | 408.982 | 2,29% | Aktien |
| GREAT POINT PARTNERS LLC | $11.076.061 | 352.180 | 1,97% | Aktien |
| ArrowMark Colorado Holdings LLC | $10.770.147 | 342.453 | 1,92% | Aktien |
| FMR LLC | $9.295.393 | 295.561 | 1,65% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $9.222.612 | 293.182 | 1,64% | Aktien |
| STATE STREET CORP | $7.054.927 | 224.322 | 1,26% | Aktien |
| FRANKLIN RESOURCES INC | $6.424.606 | 204.280 | 1,14% | Aktien |
| MORGAN STANLEY | $6.029.719 | 191.724 | 1,07% | Aktien |
| UBS Group AG | $5.387.039 | 171.289 | 0,96% | Aktien |
| BLAIR WILLIAM & CO/IL | $4.620.162 | 146.905 | 0,82% | Aktien |
| Driehaus Capital Management LLC | $4.513.956 | 143.528 | 0,80% | Aktien |
| Point72 Asset Management, L.P. | $4.463.384 | 141.920 | 0,79% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $4.454.452 | 141.636 | 0,79% | Aktien |
| Rock Springs Capital Management LP | $3.357.288 | 106.750 | 0,60% | Aktien |
| DEUTSCHE BANK AG\ | $3.354.457 | 106.660 | 0,60% | Aktien |
| NORTHERN TRUST CORP | $3.259.509 | 103.641 | 0,58% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.185.131 | 101.276 | 0,57% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.006.651 | 95.601 | 0,53% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.905.980 | 92.400 | 0,52% | Kaufoption |
| DAFNA Capital Management LLC | $2.800.056 | 89.032 | 0,50% | Aktien |
| Woodline Partners LP | $2.636.611 | 83.835 | 0,47% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.335.540 | 74.262 | 0,42% | Aktien |
| Trexquant Investment LP | $2.319.815 | 73.762 | 0,41% | Aktien |
| JPMORGAN CHASE & CO | $1.997.551 | 61.882 | 0,36% | Aktien |
| XTX Topco Ltd | $1.743.085 | 55.424 | 0,31% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.688.244 | 52.300 | 0,30% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.343.984 | 42.734 | 0,24% | Aktien |
| Raiffeisen Bank International AG | $1.097.520 | 34.000 | 0,20% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.029.736 | 32.742 | 0,18% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.026.150 | 32.628 | 0,18% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $987.310 | 31.393 | 0,18% | Aktien |
| Bank of New York Mellon Corp | $903.897 | 28.741 | 0,16% | Aktien |
| Nuveen, LLC | $875.065 | 27.824 | 0,16% | Aktien |
| CITADEL ADVISORS LLC | $839.715 | 26.700 | 0,15% | Kaufoption |
| JANE STREET GROUP, LLC | $820.499 | 26.089 | 0,15% | Aktien |
| Quadrature Capital Ltd | $764.864 | 24.320 | 0,14% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $733.729 | 23.330 | 0,13% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Rachel McMinn, Ph.D. | 21. Dezember 2023 | · | Erste Einreichung | Passive Anlage | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×18 Einreichungen | 20. Dezember 2023 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Redmile Group, LLC, Jeremy C. Green | 27. Juli 2023 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Jonathan G. Drachman | 27. Dezember 2019 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 37 Insider · 18 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Rachel Mcminn | Chief Executive Officer | 22. September 2026 M | 1.345.063 | 0 | 1 | $-73.979 |
| Jonathan G Drachman | President and CEO | 2. August 2022 A | 25.000 | 0 | 0 | $0 |
| David Main | President and CEO | 7. August 2018 A | 71.530 | 0 | 0 | $0 |
| Christine Mikail Cvijic | President and CFO | 7. Juli 2026 S | 84.040 | 0 | 12 | $-900.010 |
| Sean Michael Smith | Interim CFO, Prin Acct Off | 10. August 2023 M | 21.637 | 0 | 0 | $0 |
| Robert Ho | Chief Financial Officer | 1. Februar 2022 A | 21.503 | 0 | 0 | $0 |
| Kamran Alam | CFO, Vice President Finance | 7. August 2018 A | 0 | 0 | 0 | $0 |
| Lloyd Mackenzie | Chief Operating Officer | 7. August 2018 A | 0 | 0 | 0 | $0 |
| Christina Shafer | Chief Commercial Officer | 5. Mai 2026 A | · | 0 | 0 | $0 |
| Julie Jordan | Chief Medical Officer | 26. März 2026 S | 12.472 | 0 | 1 | $-18.125 |
| Stuart Cobb | Chief Scientific Officer | 13. März 2026 S | 30.497 | 0 | 3 | $-141.446 |
| Donna Cochener | General Counsel, SVP Legal | 2. August 2022 A | · | 0 | 0 | $0 |
| Carl Walkey | Senior Vice President | 2. August 2022 A | 1.352.489 | 0 | 0 | $0 |
| Holly Vance | General Counsel | 3. August 2021 A | · | 0 | 0 | $0 |
| Shelley Mccloskey | VP, HR and Administration | 7. August 2018 A | · | 0 | 0 | $0 |
| Abigail Jenkins | Chief Commercial Officer | 9. März 2018 A | · | 0 | 0 | $0 |
| David Chilton Mitchell | VP Global Regulatory & Quality | 8. März 2017 A | 3.575 | 0 | 0 | $0 |
| Stephen B Shrewsbury | CMO; Senior VP Clinical Dev. | 10. März 2016 A | · | 0 | 0 | $0 |
| Cory S. Freedland | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Sarah B. Noonberg | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Rohan Palekar | Direktor | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Robert Keith Woods | Direktor | 12. Juni 2025 A | · | 0 | 0 | $0 |
| Keith Woods | Direktor | 16. Januar 2024 A | · | 0 | 0 | $0 |
| Erin Lavelle | Direktor | 8. Juni 2023 A | · | 0 | 0 | $0 |
| Martin Babler | Direktor | 8. Juni 2023 A | · | 0 | 0 | $0 |
| Todd E Simpson | Direktor | 8. Juni 2023 A | · | 0 | 0 | $0 |
| Erin M. Lavelle | Direktor | 11. Mai 2021 A | · | 0 | 0 | $0 |
| Lewis T Williams | Direktor | 11. Mai 2021 A | · | 0 | 0 | $0 |
| Sean P. Nolan | Direktor | 5. Mai 2020 A | · | 0 | 0 | $0 |
| Daniel J Levitt | Direktor | 14. Mai 2018 M | 0 | 0 | 0 | $0 |
| Gary Bridger | Direktor | 7. Mai 2018 A | 0 | 0 | 0 | $0 |
| Robert Pelzer | Direktor | 7. Mai 2018 A | · | 0 | 0 | $0 |
| Pfizer Inc. | 10%-Eigentümer | 10. August 2015 S | 975.403 | 0 | 0 | $0 |
| Ventures West 8 Limited Partnership | 10%-Eigentümer | 12. März 2014 C | 1.543.989 | 0 | 0 | $0 |
| Robert Baffi | · | 20. Februar 2026 A | · | 0 | 0 | $0 |
| Patel Priti | · | 31. März 2023 M | 37.313 | 0 | 0 | $0 |
| Barbara Troupin | · | 9. März 2018 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 20 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,76% | 10.681 NS | 31. Juli 2026 | N-PORT |
| IBRN · iShares Trust | 0,48% | 986 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,10% | 38.527 SH | 11. September 2026 | Täglich |
| IBB · iShares Trust | 0,04% | 120.007 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 1.426 SH | 1. Oktober 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 9.854 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 290.868 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 5.395 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 65.030 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 12.679 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 400 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1.381 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 4.511 SH | 3. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 3.984 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 796 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 126.680 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 397.791 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 722 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 19.995 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 104.527 SH | 11. September 2026 | Täglich |
NGNE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 15 Analysten
KAUF
Median-Ziel
$65.00
+153,4%
6 40,0%
Starker Kauf
8 53,3%
Kauf
1 6,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-03Mittelwert-Ziel $80.43 +213,6%
← Unter allen Zielen
Aktueller Preis $25.65
Tief$46.00
Mittelwert$80.43
Hoch$166.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 11, 2026